Clinical trial
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
NCT00249574 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00249574 |
|---|---|
| Title | Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 |
| Official title | HCV Treatment of IDUs After Buprenorphine Stabilization |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | Organization to Achieve Solutions in Substance Abuse (OASIS) |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hepatitis C, Heroin Dependence |
| Intervention type | Drug |
| Interventions | Buprenorphine/naloxone, pegInterferon |
| Enrollment | 10 |
| Start date | Jun 1, 2003 |
| Primary completion | Mar 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Nov 7, 2005 |
| Last update posted | Jan 16, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: